ATE222102T1 - Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung - Google Patents

Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung

Info

Publication number
ATE222102T1
ATE222102T1 AT95943756T AT95943756T ATE222102T1 AT E222102 T1 ATE222102 T1 AT E222102T1 AT 95943756 T AT95943756 T AT 95943756T AT 95943756 T AT95943756 T AT 95943756T AT E222102 T1 ATE222102 T1 AT E222102T1
Authority
AT
Austria
Prior art keywords
aquencry
medications
increase
water outflow
glaucoma treatment
Prior art date
Application number
AT95943756T
Other languages
English (en)
Inventor
James D Brandt
Martha E O'donnell
Fitz-Roy E Curry
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/353,442 external-priority patent/US5585401A/en
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE222102T1 publication Critical patent/ATE222102T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95943756T 1994-12-09 1995-12-08 Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung ATE222102T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/353,442 US5585401A (en) 1994-12-09 1994-12-09 Method for enhancing outflow of aqueous humor in treatment of glaucoma
US08/568,389 US5763491A (en) 1994-12-09 1995-12-06 Method for enhancing outflow of aqueous humor in treatment of glaucoma
PCT/US1995/016117 WO1996017602A1 (en) 1994-12-09 1995-12-08 A method for enhancing outflow of aqueous humor in treatment of glaucoma

Publications (1)

Publication Number Publication Date
ATE222102T1 true ATE222102T1 (de) 2002-08-15

Family

ID=26997937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95943756T ATE222102T1 (de) 1994-12-09 1995-12-08 Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung

Country Status (7)

Country Link
US (1) US5763491A (de)
EP (1) EP0794772B1 (de)
JP (1) JP2002515009A (de)
AT (1) ATE222102T1 (de)
AU (1) AU709014B2 (de)
CA (1) CA2204994A1 (de)
DE (1) DE69527799D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US6265435B1 (en) 2000-03-07 2001-07-24 Hans Rosenkoetter Method for enhancing corneal penetration by water soluble ophthalmic drugs
WO2002087564A1 (en) * 2001-04-28 2002-11-07 The Regents Of The University Of California Class of glaucoma drugs to enhance aqueous humor outflow and lower intra-ocular pressure
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
JP2009511629A (ja) * 2005-10-17 2009-03-19 ニューロセラピューティクス ファーマ， インコーポレイテッド 中枢神経系疾患の調節に有用な利尿薬様化合物類似体
US8308701B2 (en) 2010-11-15 2012-11-13 Aquesys, Inc. Methods for deploying intraocular shunts
US8852256B2 (en) 2010-11-15 2014-10-07 Aquesys, Inc. Methods for intraocular shunt placement
US8974511B2 (en) 2010-11-15 2015-03-10 Aquesys, Inc. Methods for treating closed angle glaucoma
US8758290B2 (en) 2010-11-15 2014-06-24 Aquesys, Inc. Devices and methods for implanting a shunt in the suprachoroidal space
US9095411B2 (en) 2010-11-15 2015-08-04 Aquesys, Inc. Devices for deploying intraocular shunts
US8801766B2 (en) 2010-11-15 2014-08-12 Aquesys, Inc. Devices for deploying intraocular shunts
US8721702B2 (en) 2010-11-15 2014-05-13 Aquesys, Inc. Intraocular shunt deployment devices
US8663303B2 (en) 2010-11-15 2014-03-04 Aquesys, Inc. Methods for deploying an intraocular shunt from a deployment device and into an eye
US20120123316A1 (en) 2010-11-15 2012-05-17 Aquesys, Inc. Intraocular shunts for placement in the intra-tenon's space
US8852137B2 (en) 2010-11-15 2014-10-07 Aquesys, Inc. Methods for implanting a soft gel shunt in the suprachoroidal space
US10085884B2 (en) 2006-06-30 2018-10-02 Aquesys, Inc. Intraocular devices
AU2007269259B2 (en) * 2006-06-30 2012-05-31 Aquesys Inc. Methods, systems and apparatus for relieving pressure in an organ
US8828070B2 (en) 2010-11-15 2014-09-09 Aquesys, Inc. Devices for deploying intraocular shunts
US8585629B2 (en) 2010-11-15 2013-11-19 Aquesys, Inc. Systems for deploying intraocular shunts
US10842671B2 (en) 2010-11-15 2020-11-24 Aquesys, Inc. Intraocular shunt placement in the suprachoroidal space
US8852136B2 (en) 2011-12-08 2014-10-07 Aquesys, Inc. Methods for placing a shunt into the intra-scleral space
US9610195B2 (en) 2013-02-27 2017-04-04 Aquesys, Inc. Intraocular shunt implantation methods and devices
US10080682B2 (en) 2011-12-08 2018-09-25 Aquesys, Inc. Intrascleral shunt placement
US9808373B2 (en) 2013-06-28 2017-11-07 Aquesys, Inc. Intraocular shunt implantation
US8765210B2 (en) 2011-12-08 2014-07-01 Aquesys, Inc. Systems and methods for making gelatin shunts
US9125723B2 (en) 2013-02-19 2015-09-08 Aquesys, Inc. Adjustable glaucoma implant
US10159600B2 (en) 2013-02-19 2018-12-25 Aquesys, Inc. Adjustable intraocular flow regulation
BR122020011777B1 (pt) 2013-11-14 2022-01-25 AqueSys, Inc Dispositivo de inserção para o tratamento de glaucoma
CN112998944B (zh) 2015-06-03 2023-08-22 阿奎西斯公司 外路眼内分流器放置
WO2017210627A1 (en) 2016-06-02 2017-12-07 Aquesys, Inc. Intraocular drug delivery
DE102017117657A1 (de) * 2017-08-03 2019-02-07 Carl Zeiss Meditec Ag Vorrichtung zur Beeinflussung eines Augeninnendrucks
US11246753B2 (en) 2017-11-08 2022-02-15 Aquesys, Inc. Manually adjustable intraocular flow regulation
US11135089B2 (en) 2018-03-09 2021-10-05 Aquesys, Inc. Intraocular shunt inserter
US10952898B2 (en) 2018-03-09 2021-03-23 Aquesys, Inc. Intraocular shunt inserter

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757089A (en) * 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US4895807A (en) * 1986-12-31 1990-01-23 Cherksey Bruce D Membrane channel protein and related therapeutic compounds
CA2125251C (en) * 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
EP0750608A1 (de) * 1994-01-28 1997-01-02 Cal International Limited Pharmazeutisches produkt, welches ein salicylat eines veresterbaren beta-blockers enthält
US5559151A (en) * 1994-11-30 1996-09-24 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers

Also Published As

Publication number Publication date
EP0794772A1 (de) 1997-09-17
EP0794772A4 (de) 1999-06-02
DE69527799D1 (de) 2002-09-19
EP0794772B1 (de) 2002-08-14
AU4515296A (en) 1996-06-26
AU709014B2 (en) 1999-08-19
JP2002515009A (ja) 2002-05-21
CA2204994A1 (en) 1996-06-13
US5763491A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
ATE222102T1 (de) Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung
WO2006066103A3 (en) Ophthalmic implant for treatment of glaucoma
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
EP0891753A4 (de) Künstliche hornhaut
RU2004134733A (ru) Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий
Becker et al. Epinephrine and Acetazolamide: In the therapy of the Chronic Glaucomas
Fuller et al. Traumatic choroidal rupture with late serous detachment of macula: report of successful argon laser treatment
Ronk et al. Limbal conjunctival autograft in a subacute alkaline corneal burn
Reim The results of ischaemia in chemical injuries
Khawly et al. Glaucoma associated with the nevus of Ota
ATE144139T1 (de) Verwendung von phenylethanolaminen zur herstellung von medikamenten gegen augenleiden
Maire Van Gogh's suicide
CN206411352U (zh) 一种角膜接触镜
BE893637A (fr) 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropyl-amino-propan-2-ol en vue de reduire la pression intra-oculaire et agent ophtalmique contenant ce comose
PT1021184E (pt) Utilizacao de flunarizina para o tratamento topico da hipertensao ocular
ATE227135T1 (de) Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen
AU2129200A (en) Use of nerve growth factor for therapy of intraocular tissue pathologies
Koerner et al. Inflow and outflow relations after intraocular fluid—Healon exchange in a case of chronic ocular hypotension
Zauberman et al. Keratoplasty With Glued-On Lenses for Alkali Burns: An Experimental Study
ATE114461T1 (de) Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma.
HAISTEN et al. Cyclodialysis with air injection: Technique and results in ninety-four consecutive operations
KR880013535A (ko) 안과처방액의 자가투여 장치와 투여방법
CN202522786U (zh) 青光眼眼镜

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties